Brii Biosciences Limited (2137.HK)

HKD 2.09

(7.18%)

Revenue Summary of Brii Biosciences Limited

Brii Biosciences Limited's latest annual revenue in 2023 was 617 Thousand CNY , down -98.8% from previous year.
Brii Biosciences Limited's latest quarterly revenue in 2024 Q2 was 11.07 Million CNY , down 0.0% from previous quarter.
Brii Biosciences Limited reported a annual revenue of 51.62 Million CNY in annual revenue 2022, down -44.21% from previous year.
Brii Biosciences Limited reported a annual revenue of 92.54 Million CNY in annual revenue 2021, up 12.56% from previous year.
Brii Biosciences Limited reported a quarterly revenue of 11.07 Million CNY for 2024 Q1, up 36.55% from previous quarter.
Brii Biosciences Limited reported a quarterly revenue of 8.11 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Brii Biosciences Limited (2023 - 2019)

Historical Annual Revenue of Brii Biosciences Limited (2023 - 2019)

Year	Revenue	Revenue Growth
2023	617 Thousand CNY	-98.8%
2022	51.62 Million CNY	-44.21%
2021	92.54 Million CNY	12.56%
2020	82.21 Million CNY	307.1%
2019	20.19 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q2	11.07 Million CNY	0.0%
2024 Q1	11.07 Million CNY	36.55%
2023 Q4	8.11 Million CNY	0.0%
2023 FY	617 Thousand CNY	-98.8%
2023 Q3	8.11 Million CNY	-59.54%
2023 Q2	20.04 Million CNY	0.0%
2023 Q1	20.04 Million CNY	-57.52%
2022 Q2	13.94 Million CNY	0.0%
2022 Q1	13.94 Million CNY	-40.52%
2022 FY	51.62 Million CNY	-44.21%
2022 Q4	47.19 Million CNY	0.0%
2022 Q3	47.19 Million CNY	238.51%
2021 Q1	22.83 Million CNY	-25.29%
2021 FY	92.54 Million CNY	12.56%
2021 Q3	23.44 Million CNY	2.68%
2021 Q4	23.44 Million CNY	0.0%
2021 Q2	22.83 Million CNY	0.0%
2020 FY	82.21 Million CNY	307.1%
2020 Q4	30.55 Million CNY	0.0%
2020 Q3	30.55 Million CNY	189.57%
2020 Q2	10.55 Million CNY	0.0%
2020 Q1	10.55 Million CNY	0.0%
2019 FY	20.19 Million CNY	0.0%

Peer Revenue Comparison of Brii Biosciences Limited

Name	Revenue	Revenue Difference
Uni-Bio Science Group Limited	484.71 Million HKD	99.873%
CK Life Sciences Int'l., (Holdings) Inc.	5.32 Billion HKD	99.988%